Dossier
Lannett
Coverage of Lannett in the Nexus archive.
- STAT+: Sandoz to pay $478.5 million to settle price-fixing allegations in long-running battle with states
Sandoz agreed to pay $478.5 million to settle allegations of price-fixing generic drugs, including $400 million over seven years to states and $28.5 million to resellers. The company denied wrongdoing as part of a long-running legal battle with states and resellers over inflated drug prices.
- Minnesota joins $29.6M settlement over generic drug price fixing
Minnesota joined a $29.6 million nationwide settlement with Glenmark over allegations of price fixing in generic prescription drugs. The state's share is $187,000, part of over $560,000 recovered from settlements with multiple drug makers. Consumers who purchased drugs from these companies between 2009 and 2019 may be eligible for compensation.